ArticleScientific reports2020

Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.

Paul B Noto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.